全球癌症支持性治療藥物市場研究報告 - 行業分析、規模、佔有率、成長、趨勢和2023年至2030年預測

到2030年，全球癌症支持性治療藥物的需求將從2022年的19.21百萬美元達到近27.32百萬美元，2023-2030年期間的複合成長率為4.5%。

癌症護理支援藥物是那些用於通過保護特定器官或細胞來減少癌症治療的有害副作用的藥物。這些藥物不用於癌症治療。支援性藥物有時也稱為保護性藥物。涉及癌症支援性治療的主要藥物類別包括用於治療貧血的ESA（CIA），用於中性粒細胞減少症（CIN）的G-CSF，用於癌症誘發的骨病的雙膦酸鹽，用於噁心和嘔吐的止吐藥（CINV）以及用於治療癌症疼痛的非甾體抗炎藥。癌症支援藥物的副作用主要取決於：藥物類型、給藥劑量和患者的整體健康情況。

市場動態：

全球癌症患病率的增加以及與癌症治療相關的許多副作用是推動預測時間範圍內癌症支援性護理藥物市場的主要因素。除此之外，生物仿製葯的採用增加和有效治療方法的可用性是推動癌症支援性護理藥物市場增長的其他因素。此外，全球醫療保健支出的增加和有益的醫療保健改革正在對市場增長產生積極影響。此外，靶向治療藥物的技術進步，其副作用比傳統的癌症治療藥物小，預計將在未來幾年產生更多的需求。

該報告涵蓋了波特的五力模型，市場吸引力分析和價值鏈分析。這些工具有助於清楚地瞭解行業結構，並在全球範圍內評估競爭吸引力。

此外，這些工具還對全球癌症支持性護理藥物市場的每個應用/產品領域進行了全面評估。

區域分析：

這一部分涵蓋了區域分類，強調了北美、歐洲、亞太、拉美、中東和非洲的癌症支持性護理藥物市場的當前和未來需求。此外，報告還關注了所有主要地區的個別應用部分的需求。

該研究報告還涵蓋了市場中主要參與者的全面概況和對全球競爭格局的深入看法。癌症支持性護理藥物市場的主要參與者包括Amgen Inc、Merck & Co.公司、強生服務公司、Heron Therapeutics公司、諾華公司、葛蘭素史克公司（GSK）、F. Hoffmann-La Roche有限公司、Helsinn Healthcare SA。這一部分包括對競爭格局的整體看法，其中包括各種戰略發展，如主要的合併和收購、未來的能力、夥伴關係、財務概況、合作、新產品的開發、新產品的推出以及其他發展。

如果你有任何定製要求，請寫信給我們。我們的研究團隊可以根據您的需要提供定製報告。

目錄

第1章：前言

• 報告描述
  • 目的
  • 目標受眾
  • 獨特的銷售主張（USP）和產品
• 研究範圍
• 研究方法
  • 市場研究過程
  • 市場研究方法

第二章：執行摘要

• 癌症支持性護理藥物市場的亮點
• 全球癌症支持性護理藥物市場概況

第三章：癌症支持性治療藥物- 行業分析

• 簡介
• 癌症支持性護理藥物市場的驅動因素
• 癌症支持性護理藥物市場的限制因素
• 癌症支持性護理藥物市場的機會
• 癌症輔助治療藥物市場的趨勢
• 癌症輔助治療藥物市場的波特五力分析
• 癌症輔助治療藥物的市場吸引力分析
  • 按治療類別分類的市場吸引力分析
  • 市場吸引力分析：按地區分類

第四章：價值鏈分析

• 癌症支持性護理藥物價值鏈分析
• 癌症支持性護理藥物原料分析
  • 原料清單
  • 癌症輔助治療藥物原料廠家列表
  • 癌症輔助治療藥物主要原料的價格趨勢
• 潛在買家名單
• 行銷管道
  • 直接行銷
  • 間接行銷
  • 行銷管道的發展趨勢

第五章：COVID-19爆發的影響分析

第六章：全球癌症支持性治療藥物市場分析：按治療類別分類

• 按治療類別概述
• 2015-2018年曆史數據
• 全球癌症支持性護理藥物市場按治療類別分析
• G-CSFs（粒細胞集落刺激因子）的市場分析：按地區分類
• ESAs（紅細胞刺激劑）的市場分析：按地區分類
• 抗化妝品的市場分析：按地區分類
• 雙磷酸鹽的市場分析：按地區分類
• 鴉片類藥物的市場分析：按地區分類
• 非類固醇抗發炎藥（NSAIDs）的市場分析：按地區分類

第七章：全球癌症支持性治療藥物市場分析：按地理區域分類

• 區域展望
• 簡介
• 北美洲
  • 概述和歷史數據
  • 北美癌症支持性治療藥物市場估計：按市場分類
  • 北美癌症支持性治療藥物市場估計：按國家分類
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 概述和歷史數據
  • 歐洲癌症輔助治療藥物市場估計：按市場細分分類
  • 歐洲癌症支持性治療藥物市場估計：按國家分類
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 歐洲其他地區
• 亞太地區
  • 概述和歷史數據
  • 亞太地區癌症輔助治療藥物市場估計：按市場分類
  • 亞太地區癌症輔助治療藥物市場估計：按國家分類
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳大利亞
  • 亞太其他地區
• 拉美地區
  • 概述和歷史數據
  • 拉丁美洲癌症支持性治療藥物市場估計：按市場分類
  • 拉丁美洲癌症輔助治療藥物市場估計：按國家分類
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 拉美其他地區
• 中東和非洲
  • 概述和歷史數據
  • 中東和非洲癌症輔助治療藥物市場估計：按市場分類
  • 中東和非洲癌症輔助治療藥物市場估計：按國家分類
  • 沙烏地阿拉伯
  • 阿拉伯聯合酋長國
  • 以色列
  • 南非
  • 中東和非洲其他地區

第八章：癌症支持性護理藥物公司的競爭格局

• 癌症支持性護理藥物市場競爭
• 夥伴關係/合作/協議
• 合併和收購
• 新產品發布
• 其他方面的發展

第九章：公司簡介

• 公司佔有率分析
• 市場集中度
• Amgen Inc.
  • 公司概況
  • 產品
  • 近期發展情況
• Merck & Co.
  • 公司概況
  • 產品
  • 近期發展
• Johnson & Johnson Services, Inc.
  • 公司概況
  • 產品
  • 近期發展
• Heron Theovartis
  • 公司概況
  • 產品
  • 近期發展
• Novartis AG
  • 公司概況
  • 產品
  • 近期發展
• GlaxoSmithKline plc (GSK)
  • 公司概況
  • 產品
  • 近期發展
• F. Hoffmann-La Roche Ltd.
  • 公司概況
  • 產品
  • 近期發展
• Helsinn Healthcare SA
  • 公司概況
  • 產品
  • 近期發展情況

注意- 在公司簡介中，財務細節和最近的發展情況取決於可用性，可能不包括私人公司在內。

The global demand for Cancer Supportive Care Drugs Market is presumed to reach the valuation of nearly USD 27.32 MN by 2030 from USD 19.21 MN in 2022 with a CAGR of 4.5% during the period of 2023-2030.

Cancer care supportive drugs are those drugs that are used to reduce the injurious side effects of cancer treatment by protecting specific organs or cells. These drugs are not used for cancer treatment. Supportive drugs are sometimes also called as protective drugs. The major drug classes involved in cancer supportive care include ESAs for the treatment of Anemia (CIA), G-CSFs for neutropenia (CIN), bisphosphonates for cancer-induced bone diseases, antiemetics for nausea and vomiting (CINV), and NSAIDs for treating cancer pain. The side effects of cancer supportive drugs will depend primarily on: drug type, the dose given, and the overall health of the patients.

Market Dynamics:

The increasing prevalence of cancer globally and many side effects associated with cancer treatment are the major factors driving the cancer supportive care drug market over the forecast time frame. In addition to that, increasing uptake of biosimilars and the availability of effective treatment methods are other factors that add fuel to the growth of the cancer supportive care drugs market. Also, rising expenditure on healthcare and beneficial healthcare reforms worldwide are positively impacting market growth. Moreover, the technological advancements in targeted therapy drugs, which have lesser side effects than traditional cancer therapy drugs, is anticipated to give rise to more demand in the coming years.

The report covers Porter's Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level.

Additionally, these tools also give inclusive assessment of each application/product segment in the global market of cancer supportive care drugs.

Market Segmentation:

The entire cancer supportive care drugs market has been sub-categorized into therapeutic class. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.

By Therapeutic Class

• G-CSFs (Granulocyte-colony Stimulating Factors)
• ESAs (Erythropoiesis Stimulating Agents)
• Anti-Emetics
• Bisphosphonates
• Opioids
• (Non Steroidal Anti-Inflammatory Drugs) NSAIDs

Regional Analysis:

This section covers regional segmentation which accentuates on current and future demand for cancer supportive care drugs market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the cancer supportive care drugs market include Amgen Inc, Merck & Co. Inc., Johnson & Johnson Services Inc., Heron Therapeutics Inc., Novartis AG, GlaxoSmithKline plc (GSK), F. Hoffmann-La Roche Ltd., Helsinn Healthcare SA. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Cancer Supportive Care Drugs Market
• 2.2. Global Cancer Supportive Care Drugs Market Snapshot

3 . CANCER SUPPORTIVE CARE DRUGS - INDUSTRY ANALYSIS

• 3.1. Introduction
• 3.2. Market Drivers of Cancer Supportive Care Drugs Market
• 3.3. Market Restraints of Cancer Supportive Care Drugs Market
• 3.4. Opportunities of Cancer Supportive Care Drugs Market
• 3.5. Trends of Cancer Supportive Care Drugs Market
• 3.6. Porter's Five Force Analysis of Cancer Supportive Care Drugs Market
• 3.7. Cancer Supportive Care Drugs Market Attractiveness Analysis
  • 3.7.1 Market Attractive Analysis by Therapeutic Class
  • 3.7.2 Market Attractive Analysis by Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Cancer Supportive Care Drugs Value Chain Analysis
• 4.2. Cancer Supportive Care Drugs Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Cancer Supportive Care Drugs Raw Material Manufactures List
  • 4.2.3. Price Trend of Cancer Supportive Care Drugs Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL CANCER SUPPORTIVE CARE DRUGS MARKET ANALYSIS BY THERAPEUTIC CLASS

• 6.1 Overview by Therapeutic Class
• 6.2 Historical Data 2015-2018
• 6.3 Global Cancer Supportive Care Drugs Market Analysis by Therapeutic Class
• 6.4 Market Analysis of G-CSFs (Granulocyte-colony Stimulating Factors) by Regions
• 6.6 Market Analysis of ESAs (Erythropoiesis Stimulating Agents) by Regions
• 6.5 Market Analysis of Anti-Emetics by Regions
• 6.7 Market Analysis of Bisphosphonates by Regions
• 6.8 Market Analysis of Opioids by Regions
• 6.9 Market Analysis of (Non Steroidal Anti-Inflammatory Drugs) NSAIDs by Regions

7 . GLOBAL CANCER SUPPORTIVE CARE DRUGS MARKET ANALYSIS BY GEOGRAPHY

• 7.1. Regional Outlook
• 7.2. Introduction
• 7.3. North America
  • 7.3.1. Overview and Historic Data
  • 7.3.2. North America Cancer Supportive Care Drugs Market Estimate By Market Segment
  • 7.3.3. North America Cancer Supportive Care Drugs Market Estimate By Country
  • 7.3.4. United State
  • 7.3.5. Canada
  • 7.3.6. Mexico
• 7.4. Europe
  • 7.4.1. Overview and Historic Data
  • 7.4.2. Europe Cancer Supportive Care Drugs Market Estimate by Market Segment
  • 7.4.3. Europe Cancer Supportive Care Drugs Market Estimate by Country
  • 7.4.4. United Kingdom
  • 7.4.5. France
  • 7.4.6. Germany
  • 7.4.7. Italy
  • 7.4.8. Russia
  • 7.4.9. Rest Of Europe
• 7.5. Asia Pacific
  • 7.5.1. Overview and Historic Data
  • 7.5.2. Asia Pacific Cancer Supportive Care Drugs Market Estimate by Market Segment
  • 7.5.3. Asia Pacific Cancer Supportive Care Drugs Market Estimate by Country
  • 7.5.4. China
  • 7.5.5. India
  • 7.5.6. Japan
  • 7.5.7. South Korea
  • 7.5.8. Australia
  • 7.5.9. Rest Of Asia Pacific
• 7.6. Latin America
  • 7.6.1. Overview and Historic Data
  • 7.6.2. Latin America Cancer Supportive Care Drugs Market Estimate by Market Segment
  • 7.6.3. Latin America Cancer Supportive Care Drugs Market Estimate by Country
  • 7.6.4. Brazil
  • 7.6.5. Argentina
  • 7.6.6. Peru
  • 7.6.7. Chile
  • 7.6.8. Rest of Latin America
• 7.7. Middle East & Africa
  • 7.7.1. Overview and Historic Data
  • 7.7.2. Middle East & Africa Cancer Supportive Care Drugs Market Estimate by Market Segment
  • 7.7.3. Middle East & Africa Cancer Supportive Care Drugs Market Estimate by Country
  • 7.7.4. Saudi Arabia
  • 7.7.5. UAE
  • 7.7.6. Israel
  • 7.7.7. South Africa
  • 7.7.8. Rest Of Middle East And Africa

8 . COMPETITIVE LANDSCAPE OF THE CANCER SUPPORTIVE CARE DRUGS COMPANIES

• 8.1. Cancer Supportive Care Drugs Market Competition
• 8.2. Partnership/Collaboration/Agreement
• 8.3. Merger And Acquisitions
• 8.4. New Product Launch
• 8.5. Other Developments

9 . COMPANY PROFILES OF CANCER SUPPORTIVE CARE DRUGS INDUSTRY

• 9.1. Company Share Analysis
• 9.2. Market Concentration Rate
• 9.3. Amgen Inc.
  • 9.3.1. Company Overview
  • 9.3.2. Financials
  • 9.3.3. Products
  • 9.3.4. Recent Developments
• 9.4. Merck & Co.
  • 9.4.1. Company Overview
  • 9.4.2. Financials
  • 9.4.3. Products
  • 9.4.4. Recent Developments
• 9.5. Johnson & Johnson Services, Inc.
  • 9.5.1. Company Overview
  • 9.5.2. Financials
  • 9.5.3. Products
  • 9.5.4. Recent Developments
• 9.6. Heron Theovartis
  • 9.6.1. Company Overview
  • 9.6.2. Financials
  • 9.6.3. Products
  • 9.6.4. Recent Developments
• 9.7. Novartis AG
  • 9.7.1. Company Overview
  • 9.7.2. Financials
  • 9.7.3. Products
  • 9.7.4. Recent Developments
• 9.8. GlaxoSmithKline plc (GSK)
  • 9.8.1. Company Overview
  • 9.8.2. Financials
  • 9.8.3. Products
  • 9.8.4. Recent Developments
• 9.9. F. Hoffmann-La Roche Ltd.
  • 9.9.1. Company Overview
  • 9.9.2. Financials
  • 9.9.3. Products
  • 9.9.4. Recent Developments
• 9.10. Helsinn Healthcare SA
  • 9.10.1. Company Overview
  • 9.10.2. Financials
  • 9.10.3. Products
  • 9.10.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Global Cancer Supportive Care Drugs Market Snapshot
• Drivers of The Global Cancer Supportive Care Drugs Market Impact Analysis
• Restraints of The Global Cancer Supportive Care Drugs Market Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Global Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
• Historic Data 2015-2018
• Global Cancer Supportive Care Drugs Market Analysis in G-CSFs (Granulocyte-colony Stimulating Factors) by Geography ( USD MN)
• Global Cancer Supportive Care Drugs Market Analysis in ESAs (Erythropoiesis Stimulating Agents) by Geography ( USD MN)
• Global Cancer Supportive Care Drugs Market Analysis in Anti-Emetics by Geography ( USD MN)
• Global Cancer Supportive Care Drugs Market Analysis in Bisphosphonates by Geography ( USD MN)
• Global Cancer Supportive Care Drugs Market Analysis in Opioids by Geography ( USD MN)
• Global Cancer Supportive Care Drugs Market Analysis in (Non Steroidal Anti-Inflammatory Drugs) NSAIDs by Geography ( USD MN)
• Global Cancer Supportive Care Drugs Market by Geography ( USD MN)
• Historic Data 2015-2018
• North America Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
• North America Cancer Supportive Care Drugs Market Estimate by Country ( USD MN)
• United State Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
• Canada Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
• Mexico Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
• Europe Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
• Europe Cancer Supportive Care Drugs Market Estimate by Country ( USD MN)
• United Kingdom Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
• France Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
• Germany Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
• Italy Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
• Russia Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
• Spain Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
• Rest of Europe Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
• Asia Pacific Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
• Asia Pacific Cancer Supportive Care Drugs Market Estimate by Country ( USD MN)
• China Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
• Japan Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
• India Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
• South Korea Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
• Australia Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
• Rest of Asia Pacific Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
• Latin America Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
• Latin America Cancer Supportive Care Drugs Market Estimate by Country ( USD MN)
• Brazil Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
• Argentina Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
• Peru Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
• Chile Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
• Rest of Latin America Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
• Middle East & Africa Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
• Middle East & Africa Cancer Supportive Care Drugs Market Estimate by Country ( USD MN)
• Saudi Arabia Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
• UAE Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
• Israel Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
• South Africa Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
• Rest of Middle East and Africa Cancer Supportive Care Drugs Market Analysis by Therapeutic Class ( USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisiton

LIST OF FIGURES

• Research Scope of Cancer Supportive Care Drugs Report
• Market Research Process
• Market Research Methodology
• Global Cancer Supportive Care Drugs Market Size, by Region (2019)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Therapeutic Class
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Cancer Supportive Care Drugs Market Analysis by Therapeutic Class
• Global Cancer Supportive Care Drugs Market Analysis in G-CSFs (Granulocyte-colony Stimulating Factors) by Region
• Global Cancer Supportive Care Drugs Market Analysis in ESAs (Erythropoiesis Stimulating Agents) by Region
• Global Cancer Supportive Care Drugs Market Analysis in Anti-Emetics by Region
• Global Cancer Supportive Care Drugs Market Analysis in Bisphosphonates by Region
• Global Cancer Supportive Care Drugs Market Analysis in Opioids by Region
• Global Cancer Supportive Care Drugs Market Analysis in (Non Steroidal Anti-Inflammatory Drugs) NSAIDs by Region
• Global Cancer Supportive Care Drugs Market by Revenue
• North America Cancer Supportive Care Drugs Market by Revenue
• Europe Cancer Supportive Care Drugs Market by Revenue
• Asia Pacific Cancer Supportive Care Drugs Market by Revenue
• Latin America Cancer Supportive Care Drugs Market by Revenue
• Middle East & Africa Cancer Supportive Care Drugs Market by Revenue
• Recent Development in Cancer Supportive Care Drugs Industry
• Company Market Share Analysis
• Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.